Analysis of Expression of Programmed Cell Death Ligand 1 (PD-L1) and <i>BRAF<sup>V600E</sup></i> Mutation in Thyroid Cancer

Analysis of Expression of Programmed Cell Death Ligand 1 (PD-L1) and <i>BRAF<sup>V600E</sup></i> Mutation in Thyroid Cancer

In thyroid cancer, it has been suggested that PD-L1 overexpression is associated with some clinicopathological factors and prognosis. The aim of this study is to characterize the expression of PD-L1, the presence of the <i>BRAF<sup>V600E</sup></i> mutation, as well as cellula...

Full description

Bibliographic Details
Main Authors: Mizuki Sekino, Manabu Iwadate, Yukie Yamaya, Yoshiko Matsumoto, Satoshi Suzuki, Hiroshi Mizunuma, Keiichi Nakano, Izumi Nakamura, Shinichi Suzuki
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
programmed cell death 1 ligand 1 (PD-L1)
<i>BRAF<sup>V600E</sup></i> mutation
thyroid cancer
CD8-positive T-lymphocytes
immunohistchemistry
Online Access:https://www.mdpi.com/2072-6694/15/13/3449

Internet

https://www.mdpi.com/2072-6694/15/13/3449

Similar Items